Recently, it has reported that regulating the expression of GSDMD in peripheral myeloid cells can affect microglial innate immune training and neuroinflammation in brain, thereby influencing the disease progression in h-α-synuclein A30P mutant transgenic PD mice [67]. Here, GSDMD is linked to Parkinson disease.